Related Experiment Video
Updated: Jun 7, 2025

07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
5.8K
A new cancer/testis long noncoding RNA, the OTP-AS1 RNA
Iuliia K Karnaukhova1,2, Dmitrii E Polev2,3, Larisa L Krukovskaya2
1Vavilov Institute of General Genetics, Moscow, Russia.
Scientific Reports
|November 20, 2024
Summary
Researchers identified a novel long noncoding RNA, OTP-AS1, transcribed antisense to the OTP gene. This cancer/testis RNA is highly expressed in tumors and may play a regulatory role alongside the OTP gene.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- The orthopedia homeobox (OTP) gene is crucial for brain development and mapped to chromosome 5q14.1.
- Previous studies identified OTP gene transcripts in tumors and normal testis, with ESTs suggesting longer, uncharacterized transcripts.
- Antisense transcription and long noncoding RNAs (lncRNAs) are increasingly recognized for their regulatory roles in gene expression.
Purpose of the Study:
- To identify and characterize the full-length transcript of the previously observed antisense transcription within the OTP gene locus.
- To investigate the expression pattern of this novel transcript in various human tumors and normal tissues.
- To determine the potential function and classification of the newly discovered transcript, particularly its relationship with the OTP gene.
Main Methods:
- Rapid Amplification of cDNA Ends (RACE) was employed to obtain the full-length transcript sequence.
- Bioinformatic analysis was used to determine the transcript's structure, including exon-intron boundaries and location relative to the OTP gene.
- Expression analysis was performed across a panel of human tumors and normal tissues.
Main Results:
- A novel 2436-nucleotide polyadenylated antisense transcript, designated OTP-AS1 (OTP-antisense RNA 1), was identified.
- OTP-AS1 comprises two exons, with the first located within OTP's third exon and the second within its second intron.
- OTP-AS1 was highly expressed in numerous human tumors but detected in only one normal testis sample, consistent with cancer/testis (CT) gene expression patterns.
Conclusions:
- The study discovered OTP-AS1, a novel long noncoding RNA (lncRNA) that is antisense to the OTP gene.
- OTP-AS1 exhibits characteristics of a cancer/testis (CT) RNA, with restricted expression in normal tissues but widespread presence in tumors.
- OTP-AS1 and the OTP gene may form a sense-antisense gene pair involved in regulatory interactions, potentially contributing to tumorigenesis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
RNA Splicing
56.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K

